Yu Ma
Zhejiang University
23 Papers
178 Citations
Yu Ma is an academic researcher from Zhejiang University. The author has contributed to research in topics: IGFBP7 & Colorectal cancer. The author has an hindex of 13, co-authored 21 publications.
Chat about Author
Papers
Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors
Mengyue Zheng,Ling Hou,Yu Ma,Lanyun Zhou,Fenfen Wang,Bei Cheng,Wei Wang,Bingjian Lu,Pengyuan Liu,Weiguo Lu,Yan Lu +10 more
TL;DR: Plasma exosomal miRNAs let-7d-3p and miR-30d-5p are valuable diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors and further validation using large sample sizes is required for clinical diagnosis.
Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma
Lanyun Zhou,Wei Wang,Fenfen Wang,Siqi Yang,Jiaqi Hu,Bingjian Lu,Zimin Pan,Yu Ma,Mengyue Zheng,Liyuan Zhou,Shufeng Lei,Penghong Song,Pengyuan Liu,Weiguo Lu,Yan Lu +14 more
TL;DR: Wang et al. as mentioned in this paper carried out a large plasma-derived exosomal microRNA (miRNA) studies for diagnostic biomarker discovery in endometrial cancer (EC) in patients.
IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1.
Wenjing Ruan,Jie Lin,Enping Xu,Fangying Xu,Yu Ma,Hong Deng,Qiong Huang,Bingjian Lv,Hu Hu,Jing Cui,Meijuan Di,Jiankang Dong,Maode Lai +12 more
TL;DR: It is clearly demonstrated that IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis and its expression is associated with DNA hypomethylation of exon 1.
Association of matrix metalloproteinase-2 and -9 promoter polymorphisms with colorectal cancer in Chinese.
Enping Xu,Xiaoping Xia,Bingjian Lu,Xiaoming Xing,Xiaoming Xing,Qiong Huang,Yu Ma,Wei Wang,Maode Lai +8 more
TL;DR: The results suggest that the presence of ‐1575G allele in the MMP‐2 promoter region may be of significance in the assessment of colorectal cancer risk and invasive potential.
40
Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro.
TL;DR: The findings indicate that 5-aza-dC may have anticancer function for colon cancer and restoration of IGFBP7 may involve in the biological effects induced by 5-az-dD in colon cancer cell lines, and suggest that 5.aza- dC has clinical potential in the treatment of colorectal cancer.
37